BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 38318325)

  • 1. Pediatric low-grade glioma models: advances and ongoing challenges.
    Yvone GM; Breunig JJ
    Front Oncol; 2023; 13():1346949. PubMed ID: 38318325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric Gliomas: Molecular Landscape and Emerging Targets.
    Peeters SM; Muftuoglu Y; Na B; Daniels DJ; Wang AC
    Neurosurg Clin N Am; 2021 Apr; 32(2):181-190. PubMed ID: 33781501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric brain tumors: the era of molecular diagnostics, targeted and immune-based therapeutics, and a focus on long term neurologic sequelae.
    Plant-Fox AS; O'Halloran K; Goldman S
    Curr Probl Cancer; 2021 Aug; 45(4):100777. PubMed ID: 34303558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in pediatric gliomas: from molecular characterization to personalized treatments.
    Sathyakumar S; Martinez M; Perreault S; Legault G; Bouffet E; Jabado N; Larouche V; Renzi S
    Eur J Pediatr; 2024 Jun; 183(6):2549-2562. PubMed ID: 38558313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric low-grade glioma: State-of-the-art and ongoing challenges.
    Fangusaro J; Jones DT; Packer RJ; Gutmann DH; Milde T; Witt O; Mueller S; Fisher MJ; Hansford JR; Tabori U; Hargrave D; Bandopadhayay P
    Neuro Oncol; 2024 Jan; 26(1):25-37. PubMed ID: 37944912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response and resistance to BRAF
    Capogiri M; De Micheli AJ; Lassaletta A; Muñoz DP; Coppé JP; Mueller S; Guerreiro Stucklin AS
    Front Oncol; 2022; 12():1074726. PubMed ID: 36698391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive Genomic Profiling of 282 Pediatric Low- and High-Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation Signatures.
    Johnson A; Severson E; Gay L; Vergilio JA; Elvin J; Suh J; Daniel S; Covert M; Frampton GM; Hsu S; Lesser GJ; Stogner-Underwood K; Mott RT; Rush SZ; Stanke JJ; Dahiya S; Sun J; Reddy P; Chalmers ZR; Erlich R; Chudnovsky Y; Fabrizio D; Schrock AB; Ali S; Miller V; Stephens PJ; Ross J; Crawford JR; Ramkissoon SH
    Oncologist; 2017 Dec; 22(12):1478-1490. PubMed ID: 28912153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.
    Solga AC; Toonen JA; Pan Y; Cimino PJ; Ma Y; Castillon GA; Gianino SM; Ellisman MH; Lee DY; Gutmann DH
    Oncotarget; 2017 Jul; 8(29):47206-47215. PubMed ID: 28525381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-pronged analysis of pediatric low-grade glioma reveals a unique tumor microenvironment associated with BRAF alterations.
    Zahedi S; Riemondy K; Griesinger AM; Donson AM; Fu R; Crespo M; DeSisto J; Groat MM; Bratbak E; Green A; Hankinson TC; Handler M; Vibhakar R; Willard N; Foreman NK; Levy JM
    bioRxiv; 2024 Apr; ():. PubMed ID: 38645202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Pediatric Low-Grade Gliomas.
    Sait SF; Giantini-Larsen AM; Tringale KR; Souweidane MM; Karajannis MA
    Curr Neurol Neurosci Rep; 2023 Apr; 23(4):185-199. PubMed ID: 36881254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 2021 WHO Classification of Tumors of the Central Nervous System: An update on pediatric low-grade gliomas and glioneuronal tumors.
    Bale TA; Rosenblum MK
    Brain Pathol; 2022 Jul; 32(4):e13060. PubMed ID: 35218102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Cell-Based MAPK Reporter Assay Reveals Synergistic MAPK Pathway Activity Suppression by MAPK Inhibitor Combination in
    Usta D; Sigaud R; Buhl JL; Selt F; Marquardt V; Pauck D; Jansen J; Pusch S; Ecker J; Hielscher T; Vollmer J; Sommerkamp AC; Rubner T; Hargrave D; van Tilburg CM; Pfister SM; Jones DTW; Remke M; Brummer T; Witt O; Milde T
    Mol Cancer Ther; 2020 Aug; 19(8):1736-1750. PubMed ID: 32451331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MR Imaging Characteristics and ADC Histogram Metrics for Differentiating Molecular Subgroups of Pediatric Low-Grade Gliomas.
    Shrot S; Kerpel A; Belenky J; Lurye M; Hoffmann C; Yalon M
    AJNR Am J Neuroradiol; 2022 Sep; 43(9):1356-1362. PubMed ID: 36007944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combination of novel targeted molecular agents and radiation in the treatment of pediatric gliomas.
    Dasgupta T; Haas-Kogan DA
    Front Oncol; 2013; 3():110. PubMed ID: 23717811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reimagining pilocytic astrocytomas in the context of pediatric low-grade gliomas.
    Milde T; Rodriguez FJ; Barnholtz-Sloan JS; Patil N; Eberhart CG; Gutmann DH
    Neuro Oncol; 2021 Oct; 23(10):1634-1646. PubMed ID: 34131743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T2-FLAIR Mismatch Sign in Pediatric Low-Grade Glioma.
    Wagner MW; Nobre L; Namdar K; Khalvati F; Tabori U; Hawkins C; Ertl-Wagner BB
    AJNR Am J Neuroradiol; 2023 Jul; 44(7):841-845. PubMed ID: 37348970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low Grade Gliomas in Children.
    Chalil A; Ramaswamy V
    J Child Neurol; 2016 Mar; 31(4):517-22. PubMed ID: 26286938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gliomas in children and adolescents: investigation of molecular alterations with a potential prognostic and therapeutic impact.
    Cabral de Carvalho Corrêa D; Tesser-Gamba F; Dias Oliveira I; Saba da Silva N; Capellano AM; de Seixas Alves MT; Dastoli PA; Cavalheiro S; Caminada de Toledo SR
    J Cancer Res Clin Oncol; 2022 Jan; 148(1):107-119. PubMed ID: 34626238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impact of combined epigenetic and molecular analysis of pediatric low-grade gliomas.
    Fukuoka K; Mamatjan Y; Tatevossian R; Zapotocky M; Ryall S; Stucklin AG; Bennett J; Nobre LF; Arnoldo A; Luu B; Wen J; Zhu K; Leon A; Torti D; Pugh TJ; Hazrati LN; Laperriere N; Drake J; Rutka JT; Dirks P; Kulkarni AV; Taylor MD; Bartels U; Huang A; Zadeh G; Aldape K; Ramaswamy V; Bouffet E; Snuderl M; Ellison D; Hawkins C; Tabori U
    Neuro Oncol; 2020 Oct; 22(10):1474-1483. PubMed ID: 32242226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRAF Status in Personalizing Treatment Approaches for Pediatric Gliomas.
    Olow A; Mueller S; Yang X; Hashizume R; Meyerowitz J; Weiss W; Resnick AC; Waanders AJ; Stalpers LJ; Berger MS; Gupta N; James CD; Petritsch CK; Haas-Kogan DA
    Clin Cancer Res; 2016 Nov; 22(21):5312-5321. PubMed ID: 27217440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.